GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Create Medic Co 5187.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

1,097

+1.57%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2025

Revenue

¥13.62bn

FY2016FY2025

Net income

¥713.7m

FY2016FY2025

Free cash flow

¥98.5m

FY2016FY2025

Shareholders' equity

¥16.33bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue¥13.62bn¥13.03bn¥12.59bn¥12.33bn¥11.70bn¥10.83bn¥10.84bn¥10.80bn¥10.39bn¥10.00bn
Gross profit¥5.99bn¥5.70bn¥5.48bn¥5.37bn¥5.26bn¥5.08bn¥5.23bn¥5.04bn¥4.92bn¥4.50bn
Research and development¥860.4m¥835.0m¥850.0m¥882.1m¥785.7m¥630.2m¥637.2m¥616.6m¥506.2m¥362.9m
Operating income¥1.01bn¥692.5m¥803.2m¥737.7m¥866.8m¥984.8m¥1.08bn¥993.9m¥854.0m¥754.3m
Net income¥713.7m¥840.9m¥154.0m¥482.2m¥660.4m¥659.5m¥725.1m¥672.5m¥468.0m¥516.7m
Diluted earnings per share63.3497.6416.9252.9972.6172.5177.8472.2050.2455.47

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets¥20.14bn¥20.05bn¥19.26bn¥18.87bn¥18.08bn¥17.10bn¥17.16bn¥17.39bn¥17.26bn¥17.61bn
Cash and short-term investments¥5.83bn¥6.32bn¥4.39bn¥4.31bn¥4.36bn¥3.97bn¥4.33bn¥4.28bn¥4.62bn¥5.04bn
Total liabilities¥3.81bn¥4.30bn¥4.31bn¥4.14bn¥3.86bn¥3.87bn¥3.98bn¥4.50bn¥4.39bn¥5.01bn
Debt¥749.7m¥892.0m¥884.8m¥907.8m¥815.4m¥905.9m¥1.18bn¥1.37bn¥1.59bn¥1.92bn
Shareholders' equity¥16.33bn¥15.75bn¥14.94bn¥14.72bn¥14.22bn¥13.23bn¥13.18bn¥12.89bn¥12.87bn¥12.60bn
Shares outstanding11m9m9m9m9m9m9m9m9m9m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations¥530.1m¥2.25bn¥698.8m¥461.3m¥1.25bn¥1.25bn¥880.3m¥797.9m¥524.4m¥1.44bn
Capital spending−¥431.6m−¥476.2m−¥451.9m−¥359.6m−¥619.1m−¥410.0m−¥247.0m−¥444.4m−¥305.8m−¥503.2m
Free cash flow¥98.5m¥1.77bn¥247.0m¥101.8m¥629.6m¥839.0m¥633.3m¥353.5m¥218.6m¥940.8m
Dividends paid−¥314.7m−¥348.3m−¥335.7m−¥336.0m−¥335.9m−¥344.4m−¥353.0m−¥326.0m−¥325.8m−¥331.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥3.57bn¥3.36bn¥3.56bn¥3.49bn¥3.34bn¥3.22bn¥3.52bn¥3.21bn
Gross profit¥1.44bn¥1.38bn¥1.41bn¥1.62bn¥1.55bn¥1.42bn¥1.47bn¥1.49bn
Operating income¥195.8m¥140.6m¥91.3m¥365.6m¥326.3m¥222.0m¥171.0m¥230.1m
Net income¥106.8m¥153.3m¥47.1m¥253.8m¥203.8m¥209.1m¥96.0m¥194.2m
Diluted earnings per share11.8817.054.1822.5218.0918.5511.1522.55
Total assets¥20.14bn¥19.92bn¥20.14bn¥19.15bn¥18.23bn¥19.10bn¥20.05bn¥18.83bn
Cash and short-term investments¥5.64bn¥5.43bn¥5.83bn¥5.26bn¥4.71bn¥5.76bn¥6.32bn¥5.88bn
Debt¥749.7m—¥749.7m——¥800.0m¥832.1m¥800.0m
Shareholders' equity¥16.49bn¥16.26bn¥16.33bn¥15.62bn¥15.31bn¥15.35bn¥15.75bn¥15.02bn

Financial ratios

Data as of 5 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin44.0%43.8%43.5%43.6%45.0%46.9%
Operating margin7.4%5.3%6.4%6.0%7.4%9.1%
Net margin5.2%6.5%1.2%3.9%5.6%6.1%
Return on equity4.4%5.3%1.0%3.3%4.6%5.0%
Return on assets3.5%4.2%0.8%2.6%3.7%3.9%
Free cash flow yield7.5%27.6%11.0%7.9%17.9%15.9%
Revenue growth4.5%3.5%2.1%5.4%8.0%-0.1%
Earnings growth-15.1%446.0%-68.1%-27.0%0.1%-9.0%
Current ratio7.03x4.49x4.29x4.31x4.50x4.15x
Debt to equity0.05x0.05x0.05x0.05x0.06x0.07x
Equity ratio81.1%78.6%77.6%78.0%78.7%77.4%
Interest coverage126.89x65.60x73.16x103.65x142.17x134.76x
R&D as a share of sales6.3%6.4%6.8%7.2%6.7%5.8%
Buybacks as a share of market value-30.8%5.4%-0.0%-0.0%0.0%2.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue3.4%4.7%3.5%
Operating income10.9%0.4%4.5%
Net income14.0%1.6%7.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin43.9%43.7%44.4%45.2%
Operating margin6.4%6.3%6.9%7.5%
Net margin5.8%4.2%4.7%5.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings16.29.452.716.613.513.613.513.726.017.3
Price to sales0.80.60.70.70.80.80.90.91.20.9

Dividends and splits

Per share, in the currency the company pays

Paid for 36 years. Last went ex-dividend on 29 Dec 2025.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year28.0037.0037.0037.0037.0037.0037.0036.00
  • 1.1-for-1 split · 25 Dec 1996
  • 1.2-for-1 split · 28 Dec 1993
  • 11-for-10 split · 25 Dec 1990

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.